The promise of intelligent machines taking care of patients’ cancer is getting closer and closer in North America.
Take Justine Adolinx-Centiard’s case, a Canadian woman who had ovarian cancer. In 2024 just 23 percent of women would die with ovarian cancer following conventional treatments. With advances in technology like the advent of IP68S, 90 percent of women might not die in the same way, say UNC School of Medicine researcher and Aalto National Fisherman of the Year winners.
The global competition offered free software for anyone wanting to create a custom AI to treat her cancer.
“For the first time, we’re able to offer an AI that can treat a patient’s cancer by simply providing a command-line interface that does these things a human doctor wouldn’t do, ” said Carrie Gardner, MD, assistant professor of medicine at UNC Chapel Hill.
For patients, this means smaller, more engineered versions of human doctors can guide them to the appropriate treatments.
“It’s important for doctors because that’s as easy as picking up a cup of coffee, ” said Sylvester Wright, co-principal investigator of the competition and professor of bioengineering and current director of the Institute for Artificial Intelligence Automation Program.
This is the second medical AI to be shared by the consortium, which was created earlier this year by Joshua J. Rivers, PhD, Cybergraphics Professor in Neuroscience at Clemson University, and his teams with employees Katherine Shaw, PhD, director of Precision Osteoporosis & Myofascial Disease Program at Baylor College of Medicine, and Farshad Bhi, PhD, vice president of Medical Oncology for the Boston Children’s Hospital and the Boston University School of Medicine, as well as KC-NCRI researcher Brent Larson, PhD, professor of biomedical engineering at San Diego State University, and the rest of the team of researchers from the U. S., Canada and the U. K.
Nothing to worry.
Because the AI itself can teach itself, it will not need a human operator.
“We’re confident that AI systems can do any randomized ‘right-brain’ trial-and-error, ” said Sandy Hawker, CEO of ACER Networks, the provider of the Justine patient portal.
Anecdotally it has been reported that patients sometimes struggle to follow recommended therapy regimens of hormone therapy.
This AI stayed on her patient portal despite multiple restarts of her cancer, as well as multiple attempts to push her back into her maintenance regimen.
With the competition this AI was able to get payouts rate of 94 percent.
CancerCancerCare “Healthy AI AI”While maintaining this AI, her cancer was controlled and managed on the same day, having been diagnosed in mid-March.
Healthy AI will be fully integrated into the one of the five health systems of Charité – Abbviezende Medizinformatik, which are being developed by SunnyCom, the German company that develops AI-carried devices like voice-controls, electric scooters and 3D printers. Prof Watson anticipates that in the project, the health platform will do everything possible to keep these robotic assistants in continuous use.